Omada Health (OMDA) director amends filing to show 1,435 RSUs
Rhea-AI Filing Summary
HILLEMAN JERYL L reported acquisition or exercise transactions in this Form 4 filing.
Omada Health, Inc. director Jeryl L. Hilleman received a grant of 1,435 restricted stock units of Common Stock on July 5, 2026 under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents one share, increasing her directly held beneficial ownership to 26,655 shares. This Form 4/A amends an earlier report that had understated both the RSU grant and resulting holdings due to an administrative error.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,435 shares
Net Buy
1 txn
Insider
HILLEMAN JERYL L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2 | 1,435 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 26,655 shares (Direct)
Footnotes (2)
- F1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.
- F2. This Form 4/A is being filed solely to correct the number of RSUs reported as granted on July 5, 2026, and the total number of shares beneficially owned by the Reporting Person. Due to an administrative error, the original Form 4 filing understated the number of RSUs that were granted pursuant to the Program. This amendment corrects the error to reflect the actual number of RSUs granted and the shares beneficially owned by the Reporting Person following the grant.
Key Figures
RSUs granted: 1,435 shares
Shares beneficially owned after grant: 26,655 shares
Reported transaction price per share: $0.0000 per share
3 metrics
RSUs granted
1,435 shares
Restricted stock units granted on 2026-07-05 under the Non-Employee Director Compensation Program
Shares beneficially owned after grant
26,655 shares
Director’s direct beneficial ownership following the July 5, 2026 RSU grant
Reported transaction price per share
$0.0000 per share
Per-share price reported for the Common Stock underlying the RSU grant
Key Terms
restricted stock units ("RSUs"), Non-Employee Director Compensation Program, beneficially owned, retainer fees
4 terms
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Non-Employee Director Compensation Program financial
"granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program")"
beneficially owned financial
"correct the number of RSUs reported as granted ... and the total number of shares beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
retainer fees financial
"RSUs that were granted pursuant to the Program in lieu of retainer fees"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Omada Health (OMDA) disclose in Jeryl Hilleman’s latest Form 4/A?
Omada Health reported that director Jeryl L. Hilleman received a grant of 1,435 RSUs on July 5, 2026 and now directly beneficially owns 26,655 shares of Common Stock. The amendment corrects an earlier filing that understated the grant and resulting holdings.
How many RSUs did Omada Health (OMDA) grant to director Jeryl Hilleman on July 5, 2026?
Omada Health granted director Jeryl L. Hilleman 1,435 restricted stock units (RSUs) on July 5, 2026. The RSUs were issued under the Non-Employee Director Compensation Program in lieu of cash retainer fees, with each RSU representing one share of Common Stock upon settlement.
What is Jeryl Hilleman’s total beneficial ownership in Omada Health (OMDA) after this RSU grant?
Following the corrected RSU grant, Jeryl L. Hilleman beneficially owns 26,655 shares of Omada Health Common Stock. This total reflects the updated number of RSUs granted on July 5, 2026 and her direct holdings after the compensation award reported in the Form 4/A amendment.
What does each RSU granted by Omada Health (OMDA) to Jeryl Hilleman represent?
Each RSU granted to Jeryl L. Hilleman represents the right to receive one share of Omada Health Common Stock. Settlement will occur either on a date she selects under the Non-Employee Director Compensation Program or as otherwise provided by that program’s terms.
Why did Omada Health (OMDA) file this Form 4/A amendment for Jeryl Hilleman?
The Form 4/A was filed because the original report understated the number of RSUs granted and the resulting shares beneficially owned. The amendment corrects this administrative error, updating the grant to 1,435 RSUs and post-transaction ownership to 26,655 shares.
Was Jeryl Hilleman’s Omada Health (OMDA) RSU grant part of a director compensation program?
Yes. The 1,435 RSUs reported for Jeryl L. Hilleman were granted under Omada Health’s Non-Employee Director Compensation Program. They were issued in lieu of retainer fees, aligning director compensation partly with equity through restricted stock units instead of purely cash payments.